Bill Snyder

February 15, 2013

Cure in sight for kissing bug’s bite

It’s possible to cure Chagas disease – a deadly tropical infection transmitted by “kissing bugs” – in a mouse model.

By Bill Snyder
February 14, 2013

Vaccination still key defense as flu season continues

As is the case throughout the country, this year’s flu season in Middle Tennessee is hitting elderly people particularly hard.

By Bill Snyder
February 14, 2013

Harvard’s Kahn set for Discovery Lecture

C. Ronald Kahn, M.D., renowned for his contributions to the field of insulin signaling and its role in type 2 diabetes and obesity, will deliver the next Flexner Discovery Lecture on Thursday, Feb. 21.

By Bill Snyder
February 11, 2013

VU, GlaxoSmithKline team to develop novel treatments for severe obesity

Vanderbilt University has signed a collaboration agreement with GlaxoSmithKline (GSK) for the discovery, development and commercialization of novel therapies for severe obesity.

By Bill Snyder
February 7, 2013

Humble yeast helps predict how genes are regulated

Budding yeast occupies a place of honor in the pantheon of human history. Saccharomyces cerevisiae has been used for baking and alcoholic fermentation for thousands of years.

By Bill Snyder
February 7, 2013

For people with ASD, adulthood no easy transition

One of the critical, unmet needs for people with autism spectrum disorder (ASD) is support for the transition into adulthood.

By Bill Snyder
January 31, 2013

Vanderbilt, GE unite to study colon tumor development

Vanderbilt University has partnered with GE Global Research in Niskayuna, N.Y., the technology development arm of the General Electric Company, to better define — at the cellular level — how colon tumors form and develop.
By Bill Snyder
January 31, 2013

ResearchMatch adds registry for autism disorders

ResearchMatch, a national on-line volunteer recruitment service hosted by Vanderbilt University, has launched a sub-registry for autism spectrum disorders (ASD) to increase the participation of children and adults with autism in clinical research studies.
By Bill Snyder
January 24, 2013

Pharmacology society honors Limbird’s impact

Vanderbilt University’s Lee Limbird, Ph.D., has received one of pharmacology’s highest honors — the 2013 Julius Axelrod Award from the American Society for Pharmacology and Experimental Therapeutics (ASPET).
By Bill Snyder
January 24, 2013

Toxicology society honors Guengerich

F. Peter (Fred) Guengerich, Ph.D., Stanford Moore Professor of Biochemistry, is the 2013 recipient of the Society of Toxicology Merit Award in recognition of distinguished achievements to toxicology throughout his career.
By Bill Snyder
January 24, 2013

School for Science and Math students shine in Intel competition

Seven seniors in the School for Science and Math at Vanderbilt (SSMV) made it to the semifinalist level in the Intel Science Talent Search 2013.
By Bill Snyder
January 24, 2013

Genetic testing just one weapon in HIV/AIDS fight

Genetic testing has revolutionized the treatment of patients with HIV/AIDS. But it is not a panacea.
By Bill Snyder
1 … 103 104 105 106 107 … 112